ALLN-346

engineered urate oxidase · Allena Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALLN-346, covering 2023-06-22 to 2023-06-22. Get the full timeline:

Most recent: Clinical Trial Update: An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) [Phase 2]